Global Conjunctivitis Market 2015-2019

結膜炎治療薬の世界市場:細菌性結膜炎、ウイルス性結膜炎、アレルギー性結膜炎

◆タイトル:Global Conjunctivitis Market 2015-2019
◆商品コード:IRTNTR7542
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年1月20日
◆ページ数:72
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、結膜炎治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、結膜炎治療薬の世界市場規模及び予測、市場シェア、地域別分析/市場規模、種類別分析、パイプライン分析、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Conjunctivitis

Conjunctivitis, also called pink eye or Madras eye, is an infection in or inflammation of the conjunctiva. It affects either one or both a person’s eyes and can be the result of an allergy, bacteria, or a virus. Allergens such as smoke, pollen, dust mites, eye drops, cosmetics, and perfumes can lead to conjunctivitis. It is usually associated with redness of the eye along with the release of mucoid discharges. Although the condition usually heals without medication, antibiotics are commonly used for treatment to avoid complications due to irritation of the eye.

Technavio’s analysts forecast the global conjunctivitis medication market to grow at a CAGR of 1.94% during the period 2015-2019.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global conjunctivitis medication market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of various prescription medication along with the over-the-counter (OTC) medication used to treat bacterial, viral, and allergic conjunctivitis.

The market is divided into the following segments based on geography:
• APAC
• EMEA
• Americas

Technavio’s report, Global Conjunctivitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Akorn
• Alcon
• Allergan
• Bausch & Lomb

[Other prominent vendors]
• Celsus Therapeutics
• Eleven Biotherapeutics
• Griffin Discoveries
• InSite Vision
• Merck
• Nicox
• NovaBay
• Ocular Therapeutix
• Santen Pharmaceutical
• Shire (Foresight Biotherapeutics)
• Starpharma
• Sun Pharmaceutical

[Market driver]
• Increased exposure to chemicals and pollutants
• For a full, detailed list, view our report

[Market challenge]
• Patent expiry of medication
• For a full, detailed list, view our report

[Market trend]
• Strategic alliances and M&A
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Overview: Conjunctivitis
• Types of conjunctivitis
• Signs and symptoms
• Diagnosis

PART 06: Pipeline analysis
• AC-170
• AGN-229666
• DEXTENZA
• SUN-1334H
• Auriclosene
• EBI-005
• FST-100
• SPL7013
• OPX-1
• AzaSite Xtra (ISV-405)
• GD134

PART 07: Market landscape
• Market overview
• Market size and forecast
• Conjunctivitis medication market in the US
• Bacterial conjunctivitis medication market in the US
• Viral conjunctivitis medication market in the US
• Allergic conjunctivitis medication market in the US
• Five forces analysis

PART 08: Market segmentation based on condition type
• Bacterial conjunctivitis medication
• Viral conjunctivitis medication
• Allergic conjunctivitis medication
• Global bacterial conjunctivitis medication market
• Global viral conjunctivitis medication market
• Global allergic conjunctivitis medication market

PART 09: Geographical segmentation
• Geographical segmentation of global conjunctivitis medication market
• Conjunctivitis medication market in the Americas
• Conjunctivitis medication market in EMEA
• Conjunctivitis medication market in APAC

PART 10: Market drivers
• Increased exposure to chemicals and pollutants
• Rising awareness of condition
• Exploring specific treatment for viral conjunctivitis
• Tentative approval of pipeline candidates

PART 11: Impact of drivers

PART 12: Market challenges
• Patent expiry of medication
• Contentment with existing therapies
• Adverse effects and limited efficacy of medication

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Strategic alliances and M&A
• Use of combination therapies
• Increased R&D

PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2014
• Other prominent vendors

PART 16: Key vendor analysis
• Akorn
• Alcon
• Allergan
• Bausch & Lomb

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Causes of conjunctivitis
Exhibit 03: Types of bacterial conjunctivitis
Exhibit 04: Types of viral conjunctivitis
Exhibit 05: Types of allergic conjunctivitis
Exhibit 06: Signs and symptoms of common forms of conjunctivitis
Exhibit 07: Medication used for treatment of conjunctivitis
Exhibit 08: Global conjunctivitis market: Pipeline portfolio
Exhibit 09: Global conjunctivitis market 2014-2019 ($ billions)
Exhibit 10: Conjunctivitis market in the US 2014-2019 ($ billions)
Exhibit 11: Percentage shares of conjunctivitis medication market in the US and outside the US
Exhibit 12: Segmentation of conjunctivitis medication market in US based on condition type 2014
Exhibit 13: Bacterial conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 14: Viral conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 15: Allergic conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 16: Conjunctivitis market in US: YoY growth and revenue based on condition type 2014-2019
Exhibit 17: Five forces analysis
Exhibit 18: Segmentation of global conjunctivitis medication market based on condition type
Exhibit 19: Segmentation of global conjunctivitis medication market based on condition type 2014
Exhibit 20: Global bacterial conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 21: Global viral conjunctivitis medication market 2014-2019 ($ millions)
Exhibit 22: Global allergic conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 23: Global conjunctivitis medication market: YoY growth and revenue based on condition type 2014-2019
Exhibit 24: Geographical segmentation of global conjunctivitis medication market 2014
Exhibit 25: Conjunctivitis medication market in the Americas 2014-2019 ($ billions)
Exhibit 26: Conjunctivitis medication market in EMEA 2014-2019 ($ millions)
Exhibit 27: Conjunctivitis medication market in APAC 2014-2019 ($ millions)
Exhibit 28: YoY growth and revenue of global conjunctivitis medication market by region 2014-2019
Exhibit 29: Impact of drivers
Exhibit 30: Impact of drivers and challenges
Exhibit 31: YoY growth and revenue generated from sales of ophthalmic therapeutics 2011-2013 ($ millions)
Exhibit 32: Akorn: Key takeaways
Exhibit 33: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
Exhibit 34: Percentage share of divisions of Alcon based on revenue 2014
Exhibit 35: Alcon: Key takeaways
Exhibit 36: Allergan: Key takeaways
Exhibit 37: Allergan: Business segmentation 2014 by revenue
Exhibit 38: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 39: Allergan: Geographical segmentation by revenue 2014
Exhibit 40: Bausch & Lomb: Product categories



【掲載企業】

Akorn, Alcon, Allergan, Bausch & Lomb, Celsus Therapeutics, Eleven Biotherapeutics, Griffin Discoveries, InSiteVision, Merck, Nicox, NovaBay, Ocular Therapeutix, Santen Pharmaceutical, Shire (Foresight biotherapeutics), Starpharma, Sun Pharma.

【資料のキーワード】

結膜炎治療薬、細菌性結膜炎治療、ウイルス性結膜炎治療、アレルギー性結膜炎治療、医薬品、パイプライン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[結膜炎治療薬の世界市場:細菌性結膜炎、ウイルス性結膜炎、アレルギー性結膜炎] (Global Conjunctivitis Market 2015-2019 / IRTNTR7542)販売に関する免責事項
[結膜炎治療薬の世界市場:細菌性結膜炎、ウイルス性結膜炎、アレルギー性結膜炎] (Global Conjunctivitis Market 2015-2019 / IRTNTR7542)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆